Wellington Shields Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $318K | Sell |
13,191
-2,973
| -18% | -$77.8K | 0.04% | 214 |
|
|
2026
Q1 | $454K | Buy |
16,164
+1,156
| +8% | +$30.8K | 0.07% | 165 |
|
|
2025
Q4 | $374K | Buy |
15,008
+476
| +3% | +$12K | 0.05% | 179 |
|
|
2025
Q3 | $370K | Sell |
14,532
-423
| -3% | -$10.4K | 0.06% | 180 |
|
|
2025
Q2 | $363K | Sell |
14,955
-6,473
| -30% | -$151K | 0.06% | 177 |
|
|
2025
Q1 | $543K | Sell |
21,428
-2,591
| -11% | -$67.8K | 0.1% | 135 |
|
|
2024
Q4 | $637K | Sell |
24,019
-5,711
| -19% | -$155K | 0.11% | 126 |
|
|
2024
Q3 | $860K | Sell |
29,730
-583
| -2% | -$17K | 0.15% | 116 |
|
|
2024
Q2 | $848K | Sell |
30,313
-437
| -1% | -$12K | 0.15% | 116 |
|
|
2024
Q1 | $853K | Buy |
30,750
+385
| +1% | +$10.7K | 0.16% | 114 |
|
|
2023
Q4 | $874K | Sell |
30,365
-2,158
| -7% | -$65.2K | 0.11% | 115 |
|
|
2023
Q3 | $1.08M | Buy |
32,523
+10,060
| +45% | +$356K | 0.14% | 94 |
|
|
2023
Q2 | $824K | Sell |
22,463
-1,287
| -5% | -$50.1K | 0.1% | 115 |
|
|
2023
Q1 | $969K | Sell |
23,750
-7,060
| -23% | -$305K | 0.12% | 102 |
|
|
2022
Q4 | $1.58M | Sell |
30,810
-144
| -0.5% | -$6.9K | 0.19% | 69 |
|
|
2022
Q3 | $1.35M | Sell |
30,954
-43
| -0.1% | -$2.09K | 0.32% | 80 |
|
|
2022
Q2 | $1.63M | Sell |
30,997
-16,514
| -35% | -$842K | 0.2% | 66 |
|
|
2022
Q1 | $2.47M | Sell |
47,511
-24,107
| -34% | -$1.25M | 0.27% | 57 |
|
|
2021
Q4 | $4.23M | Buy |
71,618
+17,483
| +32% | +$866K | 0.54% | 37 |
|
|
2021
Q3 | $2.33M | Sell |
54,135
-24,557
| -31% | -$1.09M | 0.32% | 65 |
|
|
2021
Q2 | $3.08M | Sell |
78,692
-15,123
| -16% | -$588K | 0.37% | 54 |
|
|
2021
Q1 | $3.4M | Sell |
93,815
-10,951
| -10% | -$389K | 0.32% | 63 |
|
|
2020
Q4 | $3.86M | Buy |
104,766
+2,148
| +2% | +$78.8K | 0.52% | 41 |
|
|
2020
Q3 | $3.57M | Sell |
102,618
-1,630
| -2% | -$57.1K | 0.57% | 39 |
|
|
2020
Q2 | $3.23M | Buy |
104,248
+3,398
| +3% | +$115K | 0.52% | 41 |
|
|
2020
Q1 | $3.12M | Sell |
100,850
-3,160
| -3% | -$108K | 0.59% | 37 |
|
|
2019
Q4 | $3.87M | Sell |
104,010
-2,592
| -2% | -$92.3K | 0.59% | 37 |
|
|
2019
Q3 | $3.63M | Buy |
106,602
+10,009
| +10% | +$364K | 0.59% | 37 |
|
|
2019
Q2 | $3.97M | Sell |
96,593
-3,522
| -4% | -$140K | 0.66% | 27 |
|
|
2019
Q1 | $4.03M | Sell |
100,115
-12,759
| -11% | -$511K | 0.69% | 24 |
|
|
2018
Q4 | $4.67M | Sell |
112,874
-723
| -0.6% | -$30K | 0.88% | 18 |
|
|
2018
Q3 | $4.75M | Buy |
113,597
+88
| +0.1% | +$3.39K | 0.77% | 23 |
|
|
2018
Q2 | $3.91M | Buy |
113,509
+9
| +0% | +$308 | 0.65% | 26 |
|
|
2018
Q1 | $3.82M | Sell |
113,500
-318
| -0.3% | -$10.9K | 0.58% | 31 |
|
|
2017
Q4 | $3.91M | Sell |
113,818
-4,101
| -3% | -$140K | 0.61% | 32 |
|
|
2017
Q3 | $3.99M | Sell |
117,919
-27,735
| -19% | -$891K | 0.66% | 30 |
|
|
2017
Q2 | $4.64M | Sell |
145,654
-722
| -0.5% | -$22.8K | 0.76% | 26 |
|
|
2017
Q1 | $4.75M | Sell |
146,376
-16,183
| -10% | -$510K | 0.77% | 23 |
|
|
2016
Q4 | $5.01M | Sell |
162,559
-5,732
| -3% | -$175K | 0.83% | 16 |
|
|
2016
Q3 | $5.41M | Sell |
168,291
-12,424
| -7% | -$415K | 0.94% | 16 |
|
|
2016
Q2 | $6.04M | Buy |
180,715
+22,285
| +14% | +$711K | 1.02% | 14 |
|
|
2016
Q1 | $4.46M | Buy |
158,430
+11,078
| +8% | +$316K | 0.78% | 25 |
|
|
2015
Q4 | $4.51M | Sell |
147,352
-260
| -0.2% | -$8.18K | 0.77% | 21 |
|
|
2015
Q3 | $4.4M | Sell |
147,612
-50,052
| -25% | -$1.6M | 0.76% | 20 |
|
|
2015
Q2 | $6.29M | Buy |
197,664
+2,019
| +1% | +$65.8K | 0.96% | 12 |
|
|
2015
Q1 | $6.46M | Sell |
195,645
-1,828
| -0.9% | -$58.1K | 0.97% | 15 |
|
|
2014
Q4 | $5.84M | Buy |
197,473
+2,432
| +1% | +$69.7K | 0.93% | 17 |
|
|
2014
Q3 | $5.47M | Buy |
195,041
+4,189
| +2% | +$118K | 0.91% | 20 |
|
|
2014
Q2 | $5.37M | Buy |
190,852
+8,798
| +5% | +$251K | 0.84% | 21 |
|
|
2014
Q1 | $5.55M | Buy |
182,054
+16,100
| +10% | +$480K | 0.95% | 15 |
|
|
2013
Q4 | $4.82M | Buy |
165,954
+6,191
| +4% | +$180K | 0.87% | 16 |
|
|
2013
Q3 | $4.35M | Buy |
159,763
+101,307
| +173% | +$2.76M | 0.83% | 15 |
|
|
2013
Q2 | $1.55M | Buy |
+58,456
| New | +$1.62M | 0.27% | 70 |
|
Other funds holding PFE
Wellington Shields Capital Management's PFE Position: Q2 2026 in Review
Wellington Shields Capital Management reduced its Pfizer (PFE) stake by 18% in Q2 2026, selling an estimated $77.8K and leaving 13,191 shares worth $318K. The position accounts for 0.04% of the portfolio, ranked #214.
Wellington Shields Capital Management first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $6.46M in Q1 2015. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Wellington Shields Capital Management held 13,191 shares of Pfizer worth $318K as of Q2 2026.
- Wellington Shields Capital Management sold 2,973 Pfizer shares in Q2 2026, an estimated $77.8K.
- Pfizer made up 0.04% of Wellington Shields Capital Management's portfolio in Q2 2026, its #214 holding.
- Wellington Shields Capital Management first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- Wellington Shields Capital Management's Pfizer position peaked at $6.46M in Q1 2015.
- 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Wellington Shields Capital Management's 13F filing for Q2 2026, filed 10 Aug 2026.